Moreover, acute p53 depletion by transient CRISPR/Cas9 transfection (TP53Δ) in HFs produced results comparable to those obtained with siRNA (Fig. 2e and Supplementary Fig. 1c), thus ruling out cell-type specific outcomes and off-target effects. This evidence concerns the gene TP53 and Hand-foot syndrome.